Dr. Eastlack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Helix 30 N Mario Capecchi Dr RM 5n141
Salt Lake City, UT 84112Phone+1 801-581-2121
Education & Training
Louisiana State University School of Medicine in New OrleansClass of 2016
Certifications & Licensure
UT State Medical License 2024 - 2026
NC State Medical License 2020 - 2024
Publications & Presentations
PubMed
- 11 citationsKnockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment.Shengli Dong, Bernardo Ruiz-Calderon, Rajamani Rathinam, Steven C. Eastlack, Mazvita Maziveyi
International Journal of Cancer. 2020-05-01 - 86 citationsKratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive ReviewSteven C. Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy. 2020-01-28 - 56 citationsSuppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancerSteven C. Eastlack, Shengli Dong, Cristina Ivan, Suresh K. Alahari
Molecular Cancer. 2018-07-16
Journal Articles
- Expression of Long Noncoding RNA MALAT1 Correlates with Increased Levels of Nischarin and Inhibits Oncogenic Cell Functions in Breast CancerSteven Eastlack, MD, PLoS One
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
